Tuesday, August 2, 2016

BRIEF-Catalyst Biosciences to sell three nicotinic receptor assets to Attenua

* Catalyst biosciences announces agreement to sell three nnr

assets to attenua

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)